Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of Ixekizumab (LY2439821) in bDMARD-Naive Participants With Radiographic Axial Spondyloarthritis

ClinicalTrials.gov ID: NCT02696785

Public ClinicalTrials.gov record NCT02696785. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 29, 2026, 8:50 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multicenter, Randomized, Double-Blind, Active and Placebo-Controlled 16-Week Study Followed by Long-Term Evaluation of Efficacy and Safety of Ixekizumab (LY2439821) in bDMARD-Naive Patients With Radiographic Axial Spondyloarthritis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main purpose of this study is to evaluate the safety and efficacy of the study drug known as ixekizumab in biological disease-modifying anti-rheumatic drugs (bDMARDs)-naive participants with radiographic axial spondyloarthritis (rad-axSpA).

Study identification

NCT ID
NCT02696785
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
341 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
May 2, 2016 (Actual)
Primary completion
Dec 8, 2017 (Actual)
Completion
Oct 17, 2018 (Actual)
Last update posted
Nov 19, 2019

2016 – 2018

United States locations

U.S. sites
19
U.S. states
15
U.S. cities
19
Facility City State ZIP Site status
Arizona Arthritis Research, PLC Phoenix Arizona 85032 —
Care Access Research - Huntington Beach Huntington Beach California 92648 —
Desert Medical Advances Palm Desert California 92260 —
Arthritis Assoc. & Osteoporosis Ctr of Colorado Springs, LLC Colorado Springs Colorado 80920 —
Denver Arthritis Center Denver Colorado 80230 —
New England Research Associates Trumbull Connecticut 06611 —
Sarasota Arthritis Center Sarasota Florida 34239 —
Marietta Rheumatology Marietta Georgia 30060 —
Center for Arthritis & Osteoporosis Elizabethtown Kentucky 42701 —
Klein and Associates MD, PA Cumberland Maryland 21502 —
Klein and Associates MD, PA Hagerstown Maryland 21740 —
Arthritis Consultants St Louis Missouri 63141 —
Glacier View Research Institute Kalispell Montana 59901 —
Physician Research Collaboration, LLC Lincoln Nebraska 68516 —
Shanahan Rheumatology & Immunotherapy Raleigh North Carolina 27617 —
Articularis Healthcare Group, INC dba Columbia Arthritis Ctr Columbia South Carolina 29204 —
Low Country Research Center North Charleston South Carolina 29406 —
Univ of Texas Health Science Center - Houston Houston Texas 77030 —
Arthritis Northwest Rheumatology Spokane Washington 99204 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02696785, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 19, 2019 · Synced Oct 29, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02696785 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →